Caplight Directory>Investors>Vivo Capital>Vivocapital


Vivo Capital

Vivo Capital

Palo Alto, Californiavivocapital.com

Overview

Vivo Capital is a global healthcare investment firm founded in 1996. It operates a multi-fund platform with strategies spanning venture capital, private equity, and public equity. The firm invests globally in various healthcare sectors, including biopharmaceuticals, specialty pharmaceuticals, medical devices, and healthcare services. Vivo Capital focuses on companies from early-stage to growth-stage and buyout deals.

Portfolio Companies

48

Investments

CompanyDateStageLead
Full-Life Technologies|HomeMay 2026Series DLead
AN2 TherapeuticsMar 2026Follow-on OfferingCo-investor
ImmunicMar 2026Post-IPO FinancingCo-investor
Candid TherapeuticsMar 2026PIPECo-investor
Faeth TherapeuticsFeb 2026Private PlacementCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersPalo Alto, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.